These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 9171938)
1. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex. Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938 [TBL] [Abstract][Full Text] [Related]
2. Gene delivery into malignant cells in vivo by a conjugated adenovirus/DNA complex. Nguyen DM; Wiehle SA; Roth JA; Cristiano RJ Cancer Gene Ther; 1997; 4(3):183-90. PubMed ID: 9171937 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122 [TBL] [Abstract][Full Text] [Related]
4. Viral and non-viral vectors for cancer gene therapy. Cristiano RJ Anticancer Res; 1998; 18(5A):3241-5. PubMed ID: 9858889 [TBL] [Abstract][Full Text] [Related]
5. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells. Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054 [TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. Ji L; Fang B; Yen N; Fong K; Minna JD; Roth JA Cancer Res; 1999 Jul; 59(14):3333-9. PubMed ID: 10416589 [TBL] [Abstract][Full Text] [Related]
7. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer. Oakley R; Phillips E; Hooper R; Wilson D; Partridge M Clin Cancer Res; 2002 Jun; 8(6):1984-94. PubMed ID: 12060644 [TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive effects by adenovirus-mediated mda-7 gene transfer in non-small cell lung cancer cell in vitro. Saeki T; Mhashilkar A; Chada S; Branch C; Roth JA; Ramesh R Gene Ther; 2000 Dec; 7(23):2051-7. PubMed ID: 11175318 [TBL] [Abstract][Full Text] [Related]
9. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line]. Wang H; Lai B; Li J Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947 [TBL] [Abstract][Full Text] [Related]
10. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238 [TBL] [Abstract][Full Text] [Related]
12. Restoration of p53 tumor-suppressor activity in human tumor cells in vitro and in their xenografts in vivo by recombinant avian adenovirus CELO-p53. Logunov DY; Ilyinskaya GV; Cherenova LV; Verhovskaya LV; Shmarov MM; Chumakov PM; Kopnin BP; Naroditsky BS Gene Ther; 2004 Jan; 11(1):79-84. PubMed ID: 14681700 [TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo. Ghaneh P; Greenhalf W; Humphreys M; Wilson D; Zumstein L; Lemoine NR; Neoptolemos JP Gene Ther; 2001 Feb; 8(3):199-208. PubMed ID: 11313791 [TBL] [Abstract][Full Text] [Related]
15. Recombinant adenovirus-p53 gene transfer and cell-specific growth suppression of human cervical cancer cells in vitro and in vivo. Ahn WS; Bae SM; Lee KH; Lee JM; Namkoong SE; Chun HJ; Kim CK; Kim YW Gynecol Oncol; 2004 Feb; 92(2):611-21. PubMed ID: 14766255 [TBL] [Abstract][Full Text] [Related]
16. Adenovirus-p53-mediated gene therapy of anaplastic large cell lymphoma with t(2;5) in a nude mouse model. Turturro F; Heineke HL; Drevyanko TF; Link CJ; Seth P Gene Ther; 2000 Jun; 7(11):930-3. PubMed ID: 10849552 [TBL] [Abstract][Full Text] [Related]
17. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer]. Wang Q; Han D; Wang W Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer. Modesitt SC; Ramirez P; Zu Z; Bodurka-Bevers D; Gershenson D; Wolf JK Clin Cancer Res; 2001 Jun; 7(6):1765-72. PubMed ID: 11410518 [TBL] [Abstract][Full Text] [Related]
19. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice. Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of multiple administrations of a recombinant adenovirus expressing wild-type p53 in an immune-competent mouse tumor model. Li Z; Rakkar A; Katayose Y; Kim M; Shanmugam N; Srivastava S; Moul JW; McLeod DG; Cowan KH; Seth P Gene Ther; 1998 May; 5(5):605-13. PubMed ID: 9797864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]